Perim Dana, Mazer-Amirshahi Maryann, Trvalik Arcadia, Pourmand Ali
Emergency Medicine Department, George Washington University School of Medicine and Health Sciences, Washington, DC.
Department of Emergency Medicine, MedStar Washington Hospital Center, and Georgetown University School of Medicine, Washington, DC.
J Emerg Med. 2019 Jun;56(6):611-623. doi: 10.1016/j.jemermed.2019.03.012. Epub 2019 Apr 16.
Heart failure is a major public health problem in the United States. Increasingly, patients with advanced heart failure that fail medical therapy are being treated with implanted ventricular assist devices (VADs).
This review provides an evidence-based summary of the current data for the evaluation and management of implanted VAD complications in an emergency department context.
With a prevalence of >5.8 million individuals and >550,000 new cases diagnosed each year, heart failure is a major public health problem in the United States. Increasingly, patients with advanced heart failure that fail medical therapy are being treated with implanted VADs. As the prevalence of patients with VADs continues to grow, they will sporadically present to the emergency department, regardless of whether the facility is a designated VAD center. As a result, all emergency physicians must be familiar with the basic principles of VAD function, as well as the diagnosis and initial management of VAD-related complications. In this review, we address these topics, with a focus on contemporary third-generation continuous flow VADs. This review will help supplement the critical care skills of emergency physicians in managing this complex patient population.
The cornerstone of managing the unstable VAD patient is rapid initiation of high-quality supportive care and recognition of device-related complications, as well as the identification and use of specialist VAD teams and other resources for support. Emergency physicians must understand VADs so that they may optimally manage these complex patients.
心力衰竭是美国的一个主要公共卫生问题。越来越多药物治疗无效的晚期心力衰竭患者正在接受植入式心室辅助装置(VAD)治疗。
本综述基于循证医学,总结了急诊科环境下植入式VAD并发症评估与管理的当前数据。
心力衰竭是美国的一个主要公共卫生问题,每年有超过580万人患病,超过55万新病例被诊断出来。越来越多药物治疗无效的晚期心力衰竭患者正在接受植入式VAD治疗。随着VAD患者数量的持续增加,他们会偶尔前往急诊科就诊,无论该医疗机构是否为指定的VAD中心。因此,所有急诊医生都必须熟悉VAD功能的基本原则,以及VAD相关并发症的诊断和初始管理。在本综述中,我们将探讨这些主题,重点关注当代第三代连续流VAD。本综述将有助于补充急诊医生在管理这类复杂患者群体时的重症护理技能。
管理不稳定VAD患者的基石是迅速启动高质量的支持性护理,识别与装置相关的并发症,以及识别并利用专业VAD团队和其他资源提供支持。急诊医生必须了解VAD,以便能够最佳地管理这些复杂患者。